References - iarc

2116. Ordonez NG, Mackay B (2000).
Brenner tumor of the ovary: a comparative
immunohistochemical and ultrastructural
study with transitional cell carcinoma of
the bladder. Ultrastruct Pathol 24: 157-167.
2117. Ordonez NG, Manning JT, Luna MA
(1981). Mixed tumor of the vulva: a report of
two cases probably arising in Bartholin's
gland. Cancer 48: 181-186.
2118. Origoni M, Rossi M, Ferrari D, Lillo F,
Ferrari AG (1999). Human papillomavirus
with co-existing vulvar vestibulitis syndrome
and vestibular papillomatosis. Int J
Gynaecol Obstet 64: 259-263.
2119. Osborne BM, Robboy SJ (1983).
Lymphomas or leukemia presenting as
ovarian tumors. An analysis of 42 cases.
Cancer 52: 1933-1943.
2120. Osborne CK (1998). Steroid hormone
receptors in breast cancer management.
Breast Cancer Res Treat 51: 227-238.
2121. Osin P, Crook T, Powles T, Peto J,
Gusterson B (1998). Hormone status of insitu
cancer in BRCA1 and BRCA2 mutation
carriers. Lancet 351: 1487.
2122. Osin P, Gusterson BA, Philp E, Waller
J, Bartek J, Peto J, Crook T (1998).
Predicted anti-oestrogen resistance in
BRCA-associated familial breast cancers.
Eur J Cancer 34: 1683-1686.
2123. Otis CN (1996). Uterine adenomatoid
tumors: immunohistochemical characteristics
with emphasis on Ber-EP4
immunoreactivity and distinction from adenocarcinoma.
Int J Gynecol Pathol 15: 146-
151.
2124. Otis CN, Powell JL, Barbuto D,
Carcangiu ML (1992). Intermediate filamentous
proteins in adult granulosa cell
tumors. An immunohistochemical study of
25 cases. Am J Surg Pathol 16: 962-968.
2125. Ott G, Katzenberger T, Greiner A,
Kalla J, Rosenwald A, Heinrich U, Ott MM,
Muller-Hermelink HK (1997). The t(11;18)
(q21;q21) chromosome translocation is a
frequent and specific aberration in lowgrade
but not high-grade malignant non-
Hodgkin's lymphomas of the mucosaassociated
lymphoid tissue (MALT)- type.
Cancer Res 57: 3944-3948.
2126. Otterbach F, Bankfalvi A, Bergner S,
Decker T, Krech R, Boecker W (2000).
Cytokeratin 5/6 immunohistochemistry
assists the differential diagnosis of atypical
proliferations of the breast.
Histopathology 37: 232-240.
2127. Ottesen GL, Graversen HP, Blichert-
Toft M, Christensen IJ, Andersen JA
(2000). Carcinoma in situ of the female
breast. 10 year follow-up results of a
prospective nationwide study. B r e a s t
Cancer Res Treat 62: 197-210.
2128. Ottesen GL, Graversen HP, Blichert-
Toft M, Zedeler K, Andersen JA (1993).
Lobular carcinoma in situ of the female
breast. Short-term results of a prospective
nationwide study. The Danish Breast
Cancer Cooperative Group. Am J Surg
Pathol 17: 14-21.
2 1 2 9 . Ottman R, Pike MC, King MC,
Casagrande JT, Henderson BE (1986).
Familial breast cancer in a populationbased
series. Am J Epidemiol 123: 15-21.
2130. Ouchi T, Monteiro AN, August A,
Aaronson SA, Hanafusa H (1998). BRCA1
regulates p53-dependent gene expression.
Proc Natl Acad Sci USA 95: 2302-2306.
2131. Outwater EK, Marchetto B, Wagner
BJ (2000). Virilizing tumors of the ovary:
imaging features. Ultrasound Obstet
Gynecol 15: 365-371.
406 References
2132. Outwater EK, Siegelman ES, Hunt JL
(2001). Ovarian teratomas: tumor types and
imaging characteristics. Radiographics 21:
475-490.
2133. Oyama T, Kashiwabara K, Yoshimoto
K, Arnold A, Koerner F (1998). Frequent
overexpression of the cyclin D1 oncogene
in invasive lobular carcinoma of the breast.
Cancer Res 58: 2876-2880.
2134. Ozguroglu M, Ersavasti G, Ilvan S,
Hatemi G, Demir G, Demirelli FH (1999).
Bilateral inflammatory breast metastases
of epithelial ovarian cancer. Am J Clin
Oncol 22: 408-410.
2135. Ozguroglu M, Ozaras R, Tahan V,
Demirkesen C, Demir G, Dogusoy G,
Buyukunal E, Serdengecti S, Berkarda B
(1999). Anorectal melanoma metastatic to
the breast. J Clin Gastroenterol 29: 197-199.
2136. Ozzello L, Gump FE (1985). The management
of patients with carcinomas in
fibroadenomatous tumors of the breast.
Surg Gynecol Obstet 160: 99-104.
2137. Östör AG (1993). Natural history of
cervical intraepithelial neoplasia: a critical
review. Int J Gynecol Pathol 12: 186-192.
2138. Östör AG (1995). Pandora's box or
Ariadne's thread? Definition and prognostic
significance of microinvasion in the
uterine cervix. Squamous lesions. Pathol
Annu 30: 103-136.
2139. Östör AG (2000). Early invasive adenocarcinoma
of the uterine cervix. Int J
Gynecol Pathol 19: 29-38.
2140. Östör AG, Duncan A, Quinn M, Rome
R (2000). Adenocarcinoma in situ of the
uterine cervix: an experience with 100
cases. Gynecol Oncol 79: 207-210.
2141. Östör AG, Fortune DW, Riley CB
(1988). Fibroepithelial polyps with atypical
stromal cells (pseudosarcoma botryoides)
of vulva and vagina. A report of 13 cases.
Int J Gynecol Pathol 7: 351-360.
2142. Östör AG, Pagano R, Davoren RA,
Fortune DW, Chanen W, Rome R (1984).
Adenocarcinoma in situ of the cervix. Int J
Gynecol Pathol 3: 179-190.
2143. Östör AG, Rome R, Quinn M (1997).
Microinvasive adenocarcinoma of the
cervix: a clinicopathologic study of 77
women. Obstet Gynecol 89: 88-93.
2144. Paavonen J (1985). Colposcopic findings
associated with human papillomavirus
infection of the vagina and the
cervix. Obstet Gynecol Surv 40: 185-189.
2145. Padberg BC, Stegner HE, von
Sengbusch S, Arps H, Schroder S (1992).
DNA-cytophotometry and immunocytochemistry
in ovarian tumours of borderline
malignancy and related peritoneal lesions.
Virchows Arch A Pathol Anat Histopathol
421: 497-503.
2146. Padmore RF, Lara JF, Ackerman DJ,
Gales T, Sigurdson ER, Ehya H, Cooper HS,
Patchefsky AS (1996). Primary combined
malignant melanoma and ductal carcinoma
of the breast. A report of two cases.
Cancer 78: 2515-2525.
2147. Page DL, Anderson TJ, Sakamoto G
(1987). Infiltrating Carcinoma:Major
Histoligical Types. WB Saunders: London.
2148. Page DL, Dixon JM, Anderson T, Lee
D, Stwewart H (1993). Invasive cribriform
carcinoma of the breast. Histopathology 7:
525-536.
2149. Page DL, Dupont WD (1990).
Anatomic markers of human premalignancy
and risk of breast cancer. Cancer 66:
1326-1335.
2150. Page DL, Kidd TE Jr., Dupont WD,
Simpson JF, Rogers LW (1991). Lobular
neoplasia of the breast: higher risk for subsequent
invasive cancer predicted by
more extensive disease. Hum Pathol 22:
1232-1239.
2151. Page DL, Salhany KE, Jensen RA,
Dupont WD (1996). Subsequent breast carcinoma
risk after biopsy with atypia in a
breast papilloma. Cancer 78: 258-266.
2152. Palacios J, Benito N, Pizarro A,
Suarez A, Espada J, Cano A, Gamallo C
(1995). Anomalous expression of P-
Cadherin in breast carcinoma. Correlation
with E-Cadherin expression and pathological
features. Am J Pathol 146: 605-612.
2153. Palacios J, Gamallo C (1998).
Mutations in the beta-catenin gene
(CTNNB1) in endometrioid ovarian carcinomas.
Cancer Res 58: 1344-1347.
2154. Palangie T, Mosseri V, Mihura J,
Campana F, Beuzeboc P, Dorval T, Garcia-
Giralt E, Jouve M, Scholl S, Asselain B,
Pouillart P. (1994). Prognostic factors in
inflammatory breast cancer and therapeu -
tic implications. Eur J Cancer 30A: 921-927.
2155. Palazzo J, Hyslop T (1998).
Hyperplastic ductal and lobular lesions
and carcinoma in situ of the breast:
Reproducibility of current diagnostic crite -
ria among community and academic based
pathologists. Breast J 4: 230-237.
2156. Palazzo JP, Gibas Z, Dunton CJ,
Talerman A (1993). Cytogenetic study of
botryoid rhabdomyosarcoma of the uterine
cervix. Virchows Arch A Pathol Anat
Histopathol 422: 87-91.
2157. Palli D, Galli M, Bianchi S, Bussolati
G, Di Palma S, Eusebi V, Gambacorta M,
Rosselli DT (1996). Reproducibility of histo -
logical diagnosis of breast lesions: results
of a panel in Italy. Eur J Cancer 32A: 603-
607.
2158. Palli D, Rosselli DT, Simoncini R,
Bianchi S (1991). Benign breast disease
and breast cancer: a case-control study in
a cohort in Italy. Int J Cancer 47: 703-706.
2159. Pallis L, Wilking N, Cedermark B,
Rutqvist LE, Skoog L (1992). Receptors for
estrogen and progesterone in breast carcinoma
in situ. Anticancer Res 12: 2113-
2115.
2160. Palmer JP, Biback SM (1954).
Primary cancer of the vagina. Am J Obstet
Gynecol 67: 377-397.
2161. Palmer JR, Anderson D, Helmrich SP,
Herbst AL (2000). Risk factors for diethylstilbestrol-associated
clear cell adenocarcinoma.
Obstet Gynecol 95: 814-820.
2162. Palmer PE, Bogojavlensky S, Bhan
AK, Scully RE (1990). Prolactinoma in wall
of ovarian dermoid cyst with hyperprolactinemia.
Obstet Gynecol 75: 540-543.
2163. Palombo F, Gallinari P, Iaccarino I,
Lettieri T, Hughes M, D'Arrigo A, Truong O,
Hsuan JJ, Jiricny J (1995). GTBP, a 160kilodalton
protein essential for mismatchbinding
activity in human cells. Science
268: 1912-1914.
2164. Pantoja E, Rodriguez-Ibanez I,
Axtmayer RW, Noy MA, Pelegrina I (1975).
Complications of dermoid tumors of the
ovary. Obstet Gynecol 45: 89-94.
2165. Paoletti M, Pridjian G, Okagaki T,
Talerman A (1987). A stromal Leydig cell
tumor of the ovary occurring in a pregnant
15-year-old girl. Ultrastructural findings.
Cancer 60: 2806-2810.
2166. Papadatos G, Rangan AM, Psarianos
T, Ung O, Taylor R, Boyages J (2001).
Probability of axillary node involvement in
patients with tubular carcinoma of the
breast. Br J Surg 88: 860-864.
2167. Papadopoulos N, Nicolaides NC, Wei
YF, Ruben SM, Carter KC, Rosen CA,
Haseltine WA, Fleischmann RD, Fraser
CM, Adams MD, Venter JC, Hamilton SR,
Petersen GM, Watson P, Lynch HT,
Peltomaki T, Mecklin JP, de la Chapelle A,
Kinzler KW, Vogelstein B. (1994). Mutation
of a mutL homolog in hereditary colon cancer.
Science 263: 1625-1629.
2168. Papchristou DN, Kinne DW, Ashikari
R, Fortner JG (1979). Melanoma of the nipple
and aerola. Br J Surg (4) 66: 287-288.
2169. Papotti M, Macri L, Bussolati G,
Reubi JC (1989). Correlative study on
neuro-endocrine differentiation and presence
of somatostatin receptors in breast
carcinomas. Int J Cancer 43: 365-369.
2170. Paradinas FJ, Browne P, Fisher RA,
Foskett M, Bagshawe KD, Newlands E
(1996). A clinical, histopathological and
flow cytometric study of 149 complete
moles, 146 partial moles and 107 non-molar
hydropic abortions. Histopathology 28: 101-
110.
2171. Paraskevas M, Scully RE (1989). Hilus
cell tumor of the ovary. A clinicopathological
analysis of 12 Reinke crystal-positive
and nine crystal-negative cases. Int J
Gynecol Pathol 8: 299-310.
2172. Parazzini F, Franceschi S, La Vecchia
C, Fasoli M (1991). The epidemiology of
ovarian cancer. Gynecol Oncol 43: 9-23.
2173. Parazzini F, La Vecchia C, Moroni S,
Chatenoud L, Ricci E (1994). Family history
and the risk of endometrial cancer. Int J
Cancer 59: 460-462.
2174. Parc YR, Halling KC, Burgart LJ,
McDonnell SK, Schaid DJ, Thibodeau SN,
Halling AC (2000). Microsatellite instability
and hMLH1/hMSH2 expression in young
endometrial carcinoma patients: associations
with family history and histopathology.
Int J Cancer 86: 60-66.
2175. Parham DM, Hagen N, Brown RA
(1992). Simplified method of grading primary
carcinomas of the breast. J Clin
Pathol 45: 517-520.
2176. Park CC, Mitsumori M, Nixon A,
Recht A, Connolly J, Gelman R, Silver B,
Hetelekidis S, Abner A, Harris JR, Schnitt
SJ (2000). Outcome at 8 years after breastconserving
surgery and radiation therapy
for invasive breast cancer: influence of
margin status and systemic therapy on
local recurrence. J Clin Oncol 18: 1668-
1675.
2177. Park J, Sun D, Genest DR, Trivijitsilp
P, Suh I, Crum CP (1998). Coexistence of
low and high grade squamous intraepithelial
lesions of the cervix: morphologic progression
or multiple papillomaviruses?
Gynecol Oncol 70: 386-391.
2178. Park JG, Park YJ, Wijnen JT, Vasen
HF (1999). Gene-environment interaction in
hereditary nonpolyposis colorectal cancer
with implications for diagnosis and genetic
testing. Int J Cancer 82: 516-519.
2179. Park JJ, Genest DR, Sun D, Crum CP
(1999). Atypical immature metaplastic-like
proliferations of the cervix: diagnostic
reproducibility and viral (HPV) correlates.
Hum Pathol 30: 1161-1165.